Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Status:
Completed

Trial end date:
2017-03-06

Target enrollment:

Participant gender:

The overall goal of this imaging trial is to evaluate [18F]MNI-952 (also known as [18F]UCB-K), a tau targeted PET radioligand.

Early Phase 1

Molecular NeuroImaging